105 related articles for article (PubMed ID: 26362850)
21. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S
Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672
[TBL] [Abstract][Full Text] [Related]
23. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
Ihn H; Yamane K; Kubo M; Tamaki K
Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HSP90 S-nitrosylation alleviates cardiac fibrosis via TGFβ/SMAD3 signalling pathway.
Zhang X; Zhang Y; Miao Q; Shi Z; Hu L; Liu S; Gao J; Zhao S; Chen H; Huang Z; Han Y; Ji Y; Xie L
Br J Pharmacol; 2021 Dec; 178(23):4608-4625. PubMed ID: 34265086
[TBL] [Abstract][Full Text] [Related]
25. Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability.
Su CT; Huang JW; Chiang CK; Lawrence EC; Levine KL; Dabovic B; Jung C; Davis EC; Madan-Khetarpal S; Urban Z
Hum Mol Genet; 2015 Jul; 24(14):4024-36. PubMed ID: 25882708
[TBL] [Abstract][Full Text] [Related]
26. The microRNA-15 family inhibits the TGFβ-pathway in the heart.
Tijsen AJ; van der Made I; van den Hoogenhof MM; Wijnen WJ; van Deel ED; de Groot NE; Alekseev S; Fluiter K; Schroen B; Goumans MJ; van der Velden J; Duncker DJ; Pinto YM; Creemers EE
Cardiovasc Res; 2014 Oct; 104(1):61-71. PubMed ID: 25103110
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor beta 1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin system.
Omura T; Kim S; Takeuchi K; Iwao H; Takeda T
Cardiovasc Res; 1994 Dec; 28(12):1835-42. PubMed ID: 7867037
[TBL] [Abstract][Full Text] [Related]
28. Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1.
Gaude H; Aznar N; Delay A; Bres A; Buchet-Poyau K; Caillat C; Vigouroux A; Rogon C; Woods A; Vanacker JM; Höhfeld J; Perret C; Meyer P; Billaud M; Forcet C
Oncogene; 2012 Mar; 31(12):1582-91. PubMed ID: 21860411
[TBL] [Abstract][Full Text] [Related]
29. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
30. Apilimod alters TGFβ signaling pathway and prevents cardiac fibrotic remodeling.
Cinato M; Guitou L; Saidi A; Timotin A; Sperazza E; Duparc T; Zolov SN; Giridharan SSP; Weisman LS; Martinez LO; Roncalli J; Kunduzova O; Tronchere H; Boal F
Theranostics; 2021; 11(13):6491-6506. PubMed ID: 33995670
[No Abstract] [Full Text] [Related]
31. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B
Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237
[TBL] [Abstract][Full Text] [Related]
32. Cdc37 is a molecular chaperone with specific functions in signal transduction.
Kimura Y; Rutherford SL; Miyata Y; Yahara I; Freeman BC; Yue L; Morimoto RI; Lindquist S
Genes Dev; 1997 Jul; 11(14):1775-85. PubMed ID: 9242486
[TBL] [Abstract][Full Text] [Related]
33. MiR-22 may Suppress Fibrogenesis by Targeting TGFβR I in Cardiac Fibroblasts.
Hong Y; Cao H; Wang Q; Ye J; Sui L; Feng J; Cai X; Song H; Zhang X; Chen X
Cell Physiol Biochem; 2016; 40(6):1345-1353. PubMed ID: 27997889
[TBL] [Abstract][Full Text] [Related]
34. Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.
Ota A; Zhang J; Ping P; Han J; Wang Y
Circ Res; 2010 Apr; 106(8):1404-12. PubMed ID: 20299663
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.
Chin GS; Liu W; Peled Z; Lee TY; Steinbrech DS; Hsu M; Longaker MT
Plast Reconstr Surg; 2001 Aug; 108(2):423-9. PubMed ID: 11496185
[TBL] [Abstract][Full Text] [Related]
36. Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells.
Gray PJ; Stevenson MA; Calderwood SK
Cancer Res; 2007 Dec; 67(24):11942-50. PubMed ID: 18089825
[TBL] [Abstract][Full Text] [Related]
37. Heat shock protein 90 inhibitor ameliorates pancreatic fibrosis by degradation of transforming growth factor-β receptor.
Peng YF; Lin H; Liu DC; Zhu XY; Huang N; Wei YX; Li L
Cell Signal; 2021 Aug; 84():110001. PubMed ID: 33812911
[TBL] [Abstract][Full Text] [Related]
38. Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts.
Mori Y; Hatamochi A; Arakawa M; Ueki H
Arch Dermatol Res; 1998 Mar; 290(3):158-62. PubMed ID: 9558492
[TBL] [Abstract][Full Text] [Related]
39. The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects.
Cannon MV; Yu H; Candido WM; Dokter MM; Lindstedt EL; Silljé HH; van Gilst WH; de Boer RA
Eur J Heart Fail; 2015 Mar; 17(3):273-82. PubMed ID: 25684370
[TBL] [Abstract][Full Text] [Related]
40. Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma.
Fukasawa H; Yamamoto T; Fujigaki Y; Misaki T; Ohashi N; Takayama T; Suzuki S; Mugiya S; Oda T; Uchida C; Kitagawa K; Hattori T; Hayashi H; Ozono S; Kitagawa M; Hishida A
Int J Cancer; 2010 Oct; 127(7):1517-25. PubMed ID: 20073064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
